A citation-based method for searching scientific literature

Alberto J Lorenzatti, Peter P Toth. Eur Cardiol 2020
Times Cited: 24







List of co-cited articles
48 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Marc S Sabatine, Robert P Giugliano, Anthony C Keech, Narimon Honarpour, Stephen D Wiviott, Sabina A Murphy, Julia F Kuder, Huei Wang, Thomas Liu, Scott M Wasserman,[...]. N Engl J Med 2017
16


Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Robert P Giugliano, Christopher P Cannon, Michael A Blazing, José C Nicolau, Ramón Corbalán, Jindřich Špinar, Jeong-Gun Park, Jennifer A White, Erin A Bohula, Eugene Braunwald. Circulation 2018
196
12

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
Francesco Cosentino, Peter J Grant, Victor Aboyans, Clifford J Bailey, Antonio Ceriello, Victoria Delgado, Massimo Federici, Gerasimos Filippatos, Diederick E Grobbee, Tina Birgitte Hansen,[...]. Eur Heart J 2020
12

Triglycerides and residual risk.
Antonio J Vallejo-Vaz, Pablo Corral, Laura Schreier, Kausik K Ray. Curr Opin Endocrinol Diabetes Obes 2020
22
13

Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins.
Gregory G Schwartz, Markus Abt, Weihang Bao, David DeMicco, David Kallend, Michael Miller, Hardi Mundl, Anders G Olsson. J Am Coll Cardiol 2015
168
12

Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol.
Kausik K Ray, Harold E Bays, Alberico L Catapano, Narendra D Lalwani, LeAnne T Bloedon, Lulu R Sterling, Paula L Robinson, Christie M Ballantyne. N Engl J Med 2019
294
8

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
Frederick E Dewey, Viktoria Gusarova, Richard L Dunbar, Colm O'Dushlaine, Claudia Schurmann, Omri Gottesman, Shane McCarthy, Cristopher V Van Hout, Shannon Bruse, Hayes M Dansky,[...]. N Engl J Med 2017
449
8

ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.
Viktoria Gusarova, Corey A Alexa, Yan Wang, Ashique Rafique, Jee Hae Kim, David Buckler, Ivory J Mintah, Lisa M Shihanian, Jonathan C Cohen, Helen H Hobbs,[...]. J Lipid Res 2015
134
8

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia.
Zahid Ahmad, Poulabi Banerjee, Sara Hamon, Kuo-Chen Chan, Aurelie Bouzelmat, William J Sasiela, Robert Pordy, Scott Mellis, Hayes Dansky, Daniel A Gipe,[...]. Circulation 2019
107
8

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Scott M Grundy, Neil J Stone, Alison L Bailey, Craig Beam, Kim K Birtcher, Roger S Blumenthal, Lynne T Braun, Sarah de Ferranti, Joseph Faiella-Tommasino, Daniel E Forman,[...]. Circulation 2019
8

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance.
Ulrich Laufs, Maciej Banach, G B John Mancini, Daniel Gaudet, LeAnne T Bloedon, Lulu Ren Sterling, Stephanie Kelly, Erik S G Stroes. J Am Heart Assoc 2019
165
8

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy.
Christie M Ballantyne, Ulrich Laufs, Kausik K Ray, Lawrence A Leiter, Harold E Bays, Anne C Goldberg, Erik Sg Stroes, Diane MacDougall, Xin Zhao, Alberico L Catapano. Eur J Prev Cardiol 2020
135
8

Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study.
Christie M Ballantyne, Maciej Banach, G B John Mancini, Norman E Lepor, Jeffrey C Hanselman, Xin Zhao, Lawrence A Leiter. Atherosclerosis 2018
169
8

Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
Mark J Graham, Richard G Lee, Teresa A Brandt, Li-Jung Tai, Wuxia Fu, Raechel Peralta, Rosie Yu, Eunju Hurh, Erika Paz, Bradley W McEvoy,[...]. N Engl J Med 2017
365
8

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Gregory G Schwartz, P Gabriel Steg, Michael Szarek, Deepak L Bhatt, Vera A Bittner, Rafael Diaz, Jay M Edelberg, Shaun G Goodman, Corinne Hanotin, Robert A Harrington,[...]. N Engl J Med 2018
8

Statin Intolerance: Some Practical Hints.
Maciej Banach, Dimitri P Mikhailidis. Cardiol Clin 2018
25
8

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.
Alberico L Catapano, Ian Graham, Guy De Backer, Olov Wiklund, M John Chapman, Heinz Drexel, Arno W Hoes, Catriona S Jennings, Ulf Landmesser, Terje R Pedersen,[...]. Eur Heart J 2016
8

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Maciej Banach, Manfredi Rizzo, Peter P Toth, Michel Farnier, Michael H Davidson, Khalid Al-Rasadi, Wilbert S Aronow, Vasilis Athyros, Dragan M Djuric, Marat V Ezhov,[...]. Expert Opin Drug Saf 2015
96
8

PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy.
Chase Board, Michael S Kelly, Michael D Shapiro, Dave L Dixon. J Cardiovasc Pharmacol 2020
6
33

Cholesterol-Lowering Agents.
Robert S Rosenson, Robert A Hegele, Wolfgang Koenig. Circ Res 2019
33
8

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis.
Min Jun, Celine Foote, Jicheng Lv, Bruce Neal, Anushka Patel, Stephen J Nicholls, Diederick E Grobbee, Alan Cass, John Chalmers, Vlado Perkovic. Lancet 2010
590
8

Novel treatment options for the management of heterozygous familial hypercholesterolemia.
Georgios Polychronopoulos, Konstantinos Tziomalos. Expert Rev Clin Pharmacol 2017
11
18


Recent advances in synthetic pharmacotherapies for dyslipidaemias.
Cesare R Sirtori, Shizuya Yamashita, Maria Francesca Greco, Alberto Corsini, Gerald F Watts, Massimiliano Ruscica. Eur J Prev Cardiol 2020
17
11


Pathophysiology of human visceral obesity: an update.
André Tchernof, Jean-Pierre Després. Physiol Rev 2013
8

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia.
Deepak L Bhatt, P Gabriel Steg, Michael Miller, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Craig Granowitz,[...]. N Engl J Med 2019
8

Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis.
Marc S Sabatine, Stephen D Wiviott, KyungAh Im, Sabina A Murphy, Robert P Giugliano. JAMA Cardiol 2018
102
8


Cardiovascular disease in Europe: epidemiological update 2016.
Nick Townsend, Lauren Wilson, Prachi Bhatnagar, Kremlin Wickramasinghe, Mike Rayner, Melanie Nichols. Eur Heart J 2016
788
8

Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
Julian P Halcox, José R Banegas, Carine Roy, Jean Dallongeville, Guy De Backer, Eliseo Guallar, Joep Perk, David Hajage, Karin M Henriksson, Claudio Borghi. BMC Cardiovasc Disord 2017
55
8

Remnant lipoproteins.
Anette Varbo, Børge G Nordestgaard. Curr Opin Lipidol 2017
50
8

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
François Mach, Colin Baigent, Alberico L Catapano, Konstantinos C Koskinas, Manuela Casula, Lina Badimon, M John Chapman, Guy G De Backer, Victoria Delgado, Brian A Ference,[...]. Eur Heart J 2020
8


Bisphenol A and the risk of cardiometabolic disorders: a systematic review with meta-analysis of the epidemiological evidence.
Fanny Rancière, Jasmine G Lyons, Venurs H Y Loh, Jérémie Botton, Tamara Galloway, Tiange Wang, Jonathan E Shaw, Dianna J Magliano. Environ Health 2015
154
8


Achieving adherence to lipid-lowering regimens.
W Virgil Brown, Terry A Jacobson, Lynne T Braun. J Clin Lipidol 2013
2
100

Why does Russia have such high cardiovascular mortality rates? Comparisons of blood-based biomarkers with Norway implicate non-ischaemic cardiac damage.
Olena Lakunchykova, Maria Averina, Tom Wilsgaard, Hugh Watkins, Sofia Malyutina, Yulia Ragino, Ruth H Keogh, Alexander V Kudryavtsev, Vadim Govorun, Sarah Cook,[...]. J Epidemiol Community Health 2020
8
25

Major lipids, apolipoproteins, and risk of vascular disease.
Emanuele Di Angelantonio, Nadeem Sarwar, Philip Perry, Stephen Kaptoge, Kausik K Ray, Alexander Thompson, Angela M Wood, Sarah Lewington, Naveed Sattar, Chris J Packard,[...]. JAMA 2009
8

The independent relationship between triglycerides and coronary heart disease.
Alan Morrison, John E Hokanson. Vasc Health Risk Manag 2009
53
8


Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
Aliza Hussain, Christie M Ballantyne, Anum Saeed, Salim S Virani. Curr Atheroscler Rep 2020
19
10


Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.
Michael Miller, Neil J Stone, Christie Ballantyne, Vera Bittner, Michael H Criqui, Henry N Ginsberg, Anne Carol Goldberg, William James Howard, Marc S Jacobson, Penny M Kris-Etherton,[...]. Circulation 2011
8




Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
Stephen J Nicholls, A Michael Lincoff, Dianna Bash, Christie M Ballantyne, Philip J Barter, Michael H Davidson, John J P Kastelein, Wolfgang Koenig, Darren K McGuire, Dariush Mozaffarian,[...]. Clin Cardiol 2018
133
4

Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting.
Rutger Verbeek, Renate M Hoogeveen, Anne Langsted, Lotte C A Stiekema, Simone L Verweij, G Kees Hovingh, Nicholas J Wareham, Kay-Tee Khaw, S Matthijs Boekholdt, Børge G Nordestgaard,[...]. Eur Heart J 2018
73
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.